Protein kinase C δ is activated in mouse ovarian surface epithelial cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)

Toxicology

Volumn 195, Issue 1, 2004, Pages 1-17

  Williams, Shalmica R ^a   Son, Deok Soo ^b   Terranova, Paul F ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin (TCDD); Ovarian cancer; Perinuclear translocation; Protein kinase C delta (PKC )

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 7 ETHOXYRESORUFIN 2 DEETHYLASE; BISINDOLYLMALEIMIDE; DIACYLGLYCEROL KINASE; ETHOXYRESORUFIN; ISOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN KINASE; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C ETA; PROTEIN KINASE C GAMMA; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C LAMBDA; PROTEIN KINASE C TAU; PROTEIN KINASE C THETA; PROTEIN SUBUNIT; RECEPTOR ACTIVATED C KINASE 1; ROTTLERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL MEMBRANE; CELL NUCLEUS; CELL STIMULATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; IMMUNOFLUORESCENCE; MICROSCOPY; MOLECULE; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0347416983     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2003.08.005     Document Type: Article

References (64)

1. Andre F., Rigot V., Remacle-Bonnet M., Luis J., Pommier G., Marvaldi J. Protein kinase C-gamma, delta are involved in insulin-like growth factor I-induced migration of colonic epithelial cells. Gastroenterology. 116:1999;64-77.
2. Bagchi D., Bagchi M., Tang L., Stohs S. Comparative in vitro and in vivo protein kinase C activation by selected pesticides and transition metal salts. Toxicol. Lett. 91:1997;31-37.
3. Basu A., Weixel K.M. Comparison of protein kinase C activity and isoform expression in cisplatin-sensitive and -resistant ovarian carcinoma cells. Int. J. Cancer. 62:1995;457-460.
4. Beckman R., Lindschau C., Haller H., Hucho F., Buchner K. Differential nuclear localization of protein kinase C isoforms in neuroblastoma × glioma hybrid cells. Eur. J. Biochem. 222:1994;335-343.
5. Berghard A., Gradin K., Pongratz I., Whitelaw M., Poellinger L. Cross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome P-450IAI expression via a protein kinase C-dependent mechanism. Mol. Cell Biol. 13:1993;677-689.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. Bregoli L., Baldassare J.J., Raben D.M. Nuclear diacylglycerol kinase-theta is activated in response to alpha-thrombin. J. Biol. Chem. 276:2001;23288-23295.
8. Bryant P.L.M., Reid L.M., Schmid J.E., Buckalew A.R., Abbott B.D. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on fetal mouse urinary tract epithelium in vitro. Toxicology. 162:2001;23-34.
9. Carrier F., Owens R., Nebert D., Puga A. Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol. Cell Biol. 12:1992;1856-1863.
10. Cartee L., Kucera G.L., Nixon J.B. The effects of gemcitabine and TPA on PKC signaling in BG-1 human ovarian cancer cells. Oncol. Res. 10:1998;371-377.
11. Chen R.H., Blenis J. Identification of Xenopus S6 protein kinase homologs (pp90rsk) in somatic cells: phosphorylation and activation during initiation of cell proliferation. Mol. Cell Biol. 10:1990;3204-3215.
12. Chen Y., Tukey R. Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J. Biol. Chem. 271:1996;26261-26266.
13. DeManno D.A., Cottom J.E., Kline M.P., Peters C.A., Maizels E.T., Hunzicker-Dunn M. Follicle-stimulating hormone promotes histone H3 phosphorylation on serine-10. Mol. Endocrinol. 13:1999;91-105.
14. Disatnik M.H., Buraggi G., Mochly-Rosen D. Localization of protein kinase C isozymes in cardiac myocytes. Exp. Cell. Res. 210:1994;287-297.
15. Elbendary, A., Berchuck, A., Bast, R., 1995. Biology of epithelial ovarian cancer. In: Lawton, F., Neijt, J., Swenerton, K. (Eds.), Epithelial Cancer of the Ovary. BMJ Publishing Group, London, UK, pp. 20-35.
16. Enan E., Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem. Pharmacol. 52:1996;1599-1612.
17. el-Sabeawy F., Wang S., Overstreet J., Miller M., Lasley B., Enan E. Treatment of rats during pubertal development with 2,3,7,8-tetrachlorodibenxo-p- dioxin alters both signaling kinase activities and epidermal growth factor receptor binding in the testis and the motility and acrosomal reaction of sperm. Toxicol. Appl. Pharmacol. 150:1998;427-442.
18. Engers R., Gabbert H. Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res. Clin. Oncol. 126:2000;682-692.
19. Garrone B., Kedar P., Elarova I., Lavin M., Watters D. Approaches to determine the specific role of the delta isoform of protein kinase C. J. Biochem. Biophys. Methods. 36:1997;51-61.
20. Gomez D., Skilton G., Alonso D., Kazanietz M. The role of protein kinase C and novel phorbol ester receptors in tumor cell invasion and metastasis. Oncol. Rep. 6:1999;1363-1370.
21. Goodnight J., Mischak H., Kolch W., Mushinski J.F. Immunocytochemical localization of eight protein kinase C isozymes overexpressed in NIH 3T3 fibroblasts. J. Biol. Chem. 270:1995;9991-10001.
22. Gschwendt M. Protein kinase C delta. Eur. J. Biochem. 259:1999;555-564.
23. Guo M., Joiakim A., Dudley D., Reiners J. Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated CYP1A1 and CYP1B1 induction by 12-O-tetradecanoylphorbol-13-acetate: role of transforming growth factor beta and mitogen-activated protein kinases. Biochem. Pharmacol. 62:2001;1449-1457.
24. Kazanietz M.G. Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters. Mol. Carcinog. 28:2000;5-11.
25. Kielbassa K., Miller H.-J., Meyer H.E., Marks F., Gschwendt M. Protein kinase C delta-specific phosphorylation of the elongation factor eEF-1alpha and an eEF-1alpha peptide at threonine 431. J. Biol. Chem. 270:1995;6156-6162.
26. Kiley S., Clark K., Goodnough M., Welch D., Jaken S. Protein kinase C delta involvement in mammary tumor cell metastasis. Cancer Res. 59:1999a;3230-3238.
27. Kiley S., Clark K., Duddy S., Welch D., Jaken S. Increased protein kinase C delta in mammary tumor cells: relationship to transformation and metastatic progression. Oncogene. 18:1999b;6748-6757.
28. Kobayashi H., Suzuki M., Tanaka Y., Hirashima Y., Terao T. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C and MEK/ERK/c-jun-dependent signaling pathways. J. Biol. Chem. 276:2000;2015-2022.
29. Kramer C., Sando J., Holsapple M. Lack of direct effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on protein kinase C activity in EL4 cells. Biochem. Biophys. Res. Commun. 140:1986;267-272.
30. LaPorta C. nPKC delta, a new therapeutic marker for melanoma metastasis? Int. J. Mol. Med. 5:2000a;467-471.
31. LaPorta C., Comolli R. Overexpression of nPKCdelta in BL6 murine melanoma cells enhances TGFbeta1 release into the plasma of metastasized animals. Melanoma Res. 10:2000b;527-534.
32. IARC, 1997. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Polychlorinated Dibenzo-p-Dioxins and Polychlorinated Dibenzofurans, vol. 69. Lyon, France, 4-11 February 1997, pp. 1-631.
33. Liao L., Ramsay K., Jaken S. Protein kinase C isoforms in progressively transformed rat embryo fibroblasts. Cell. Growth Differ. 5:1994;1185-1194.
34. Loertscher J.A., Sattler C.A., Allen-Hoffmann B.L. 2,3,7,8- Tetrachlorodibenzo-p-dioxin alters the differentiation pattern of human keratinocytes in organotypic culture. Toxicol. Appl. Pharmacol. 175:2001;121-129.
35. Long P., Perdew G. Lack of an absolute requirement for the native aryl hydrocarbon receptor (AhR) and AhR nuclear translocator transactivation domains in protein kinase C-mediated modulation of the AhR pathway. Arch. Biochem. Biophys. 371:1999;246-259.
36. Long P., Pray-Grant M., Tsai J., Perdew G. Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol. Pharmacol. 53:1998;691-700.
37. Mant, J., Vessey, M., 1995. Mortality trends in ovarian cancer. In: Lawton, F., Neijt, J., Swenerton, K. (Eds.), Epithelial Cancer of the Ovary. BMJ Publishing Group, London, UK, pp. 1-12.
38. Marcinkiewicz J.L., Krishna A., Cheung C.M., Terranova P.F. Oocytic tumor necrosis factor alpha: localization in the neonatal ovary and throughout follicular development in the adult rat. Biol. Reprod. 50:1994;1251-1260.
39. Martelli A., Sang N., Borgatti P., Capitani S., Neri L. Multiple biological responses activated by nuclear protein kinase C. J. Cell. Biochem. 74:1999;499-521.
40. Masur K., Lang K., Niggemann B., Zanker K., Entschladen F. High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells. Mol. Biol. Cell. 12:2001;1973-1982.
41. Mochly-Rosen D., Gordon A.S. Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J. 12:1998;35-42.
42. Moore M., Narasimhan T., Steinberg M., Wang X., Safe S. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate. Arch. Biochem. Biophys. 305:1993;483-488.
43. Murdoch W. Ovarian surface epithelium, ovulation and carcinogenesis. Biol. Rev. Camb. Philos. Soc. 71:1996;529-543.
44. Nebert D., Puga A., Vasiliou V. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer and signal transduction. Ann. N.Y. Acad. Sci. 685:1993;624-640.
45. Ono Y., Fujigita K., Kikkawa U., Igarashi K., Nishizuka Y. The structure, expression and properties of additional members of the protein kinase c family. J. Biol. Chem. 263:1988;6927-6932.
46. Park S., Henry E.C., Gasiewicz T.A. Regulation of DNA binding activity of the ligand-activated aryl hydrocarbon receptor by tyrosine phosphorylation. Arch. Biochem. Biophys. 381:2000;302-312.
47. Pongratz I., Stromstedt P.E., Mason G.G., Poellinger L. Inhibition of the specific DNA binding activity of the dioxin receptor by phosphatase treatment. J. Biol. Chem. 266:1991;16813-16817.
48. Roby K., Taylor C., Sweetwood J., Cheng Y., Pace J., Tawfik O., Persons D., Smith P., Terranova P. Development of a syngenic mouse model for events related to ovarian cancer. Carcinogenesis. 21:2000;585-591.
49. Rodriguez G., Haisley C., Hurteau J., Moser T., Whitaker R., Bast R., Stack M. Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta. Gynecol. Oncol. 80:2001;245-253.
50. Romanova L.Y., Alexandrov I.A., Nordan R.P., Blagosklonny M.V., Mushinski J.F. Cross-talk between protein kinase C-alpha (PKC-alpha) and -delta (PKC-delta): PKC-alpha elevates the PKC-delta protein level, altering its mRNA transcription and degradation. Biochemistry. 37:1998;5558-5565.
51. Sanderson J.T., Aarts J.M., Brouwer A., Froese K.L., Denison M.S., Giesy J.P. Comparison of Ah receptor-mediated luciferase and ethoxyresorufin-O- deethylase induction in H4IIE cells: implications for their use as bioanalytical tools for the detection of polyhalogenated aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 137:1996;316-325.
52. Schafer M., Madhukar B., Swanson H., Tullis K., Denison M. Protein kinase C is not involved in Ah receptor transformation and DNA binding. Arch. Biochem. Biophys. 307:1993;267-271.
53. Schaufler K., Haslmayer P., Jager W., Pec M., Thalhammer T. The environmental toxin 2,3,7,8-tetrachlorodibenzo-p-dioxin induces cytochrome P450 activity in high passage PC 3 and DU 145 human prostate cancer cell lines. Int. J. Mol. Med. 9:2002;411-416.
54. Schullery D.S., Ostrowski J., Denisenko O.N., Stempka L., Shnyreva M., Suzuki H., Gschwendt M., Bomsztyk K. Regulated interaction of protein kinase C delta with the heterogeneous nuclear ribonucleoprotein K protein. J. Biol. Chem. 274:1999;15101-15109.
55. Son D.S., Roby K.F., Rozman K.K., Terranova P.F. Estradiol enhances and estriol inhibits the expression of CYP1A1 induced by 2,3,7,8-tetrachlorodibenzo- p-dioxin in a mouse ovarian cancer cell line. Toxicology. 176:2002;229-243.
56. Swanson H.I. DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation. Chemico-Biol. Interact. 141:2002;63-76.
57. Taylor C.C., Limbach D., Terranova P.F. Src tyrosine kinase activity is related to luteinizing hormone responsiveness: genetic manipulations using mouse MA10 Leydig cells. Endocrinology. 137:1996;5735-5738.
58. Viluksela M., Stahl B.U., Birnbaum L.S., Schramm K.-W., Kettrup A., Rozman K.K. Subchronic/chronic toxicity of a mixture of four chlorinated dibenzo-p-dioxins in rats. Toxicol. Appl. Pharmacol. 151:1998;57-69.
59. Vorderstrasse B.A., Kerkvliet N.I. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules. Toxicol. Appl. Pharmacol. 171:2001;117-125.
60. Wang Q.J., Bhattacharyya D., Garfield S., Nacro K., Marquez V.E., Blumberg P.M. Differential localization of protein kinase C delta by phorbol esters and related compounds using a fusion protein with green fluorescent protein. J. Biol. Chem. 274:1999;37233-37239.
61. Weber T., Ou X., Merchant M., Wang X., Safe S., Ramos K. Biphasic modulation of protein kinase C (PKC) activity by polychlorinated dibenzo-p-dioxins (PCDDs) in serum-deprived rat aortic smooth muscle cells. J. Biochem. Toxicol. 9:1994;113-120.
62. Weber T., Chapkin R., Davidson L., Ramos K. Modulation of protein kinase C-related signal transduction by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits cell cycle dependence. Arch. Biochem. Biophys. 328:1996;227-232.
63. Yang J. Alterations of signal transduction pathways involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced malignant transformation of human cells in culture. Chemosphere. 36:1998;3015-3031.
64. Zorn N., Russell D., Buckley A., Sauro M. Alterations in splenocyte protein kinase C (PKC) activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol. Lett. 78:1995;93-100.